View More View Less
  • 1 Markusovszky Egyetemi Oktatókórház, Szombathely, Markusovszky L. u. 5., 9700
  • | 2 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest
  • | 3 Szent István Egyetem, Állatorvos-tudományi Kar, Budapest
Open access

Cross Mark

Absztrakt

Magyarországon az évente elvégzett több mint 14 000 endoszkópos retrográd cholangiopancreatographia következtében hozzávetőlegesen 1400 pancreatitis kialakulásával, ezen belül 10 beteg halálával kell számolni. A szerzők áttekintik az endoszkópos retrográd cholangiopancreatographiát követő heveny hasnyálmirigy-gyulladás megelőzésére vonatkozó szakirodalmat, ismertetik saját tapasztalataikat. Utalnak a diagnosztikus endoszkópos retrográd cholangiopancreatographia háttérbe szorulására. Hangsúlyozzák a beavatkozás javallatának gondos mérlegelését, a kockázati tényezők elemzését. Fontosnak tartják a kanülálások számának csökkentését, a korai előmetszést, a nagy kockázatú betegekben a pancreasstent beültetését, az indometacin vagy a diclofenac alkalmazását és a megfelelő intravénás folyadékbevitelt. Orv. Hetil., 2015, 156(18), 715–719.

  • 1

    Freeman, M. L., Nelson, D. B., Sherman, S., et al.: Complications of endoscopic biliary sphincterotomy. N. Engl. J. Med., 1996, 335(13), 909–918.

  • 2

    Loperfido, S., Angelini, G., Benedetti, G., et al.: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest. Endosc., 1998, 48(1), 1–10.

  • 3

    Nagy, G., Orosz, P.: Report of Hungarian gastrointestinal endoscopic activity in 2013. [Jelentés a 2013. évi magyarországi gasztroenterológiai endoszkópos tevékenységről.] Lege Artis Med., 2014, 24(8–9), 433–435. [Hungarian]

  • 4

    Kochar, B., Akshintala, V. S., Afghani, E., et al.: Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest. Endosc., 2015, 81(1), 143–149.e9.

  • 5

    ASGE Standards of Practice Committee, Anderson, M. A., Fisher, L., Jain, R., et al.: Complications of ERCP. Gastrointest. Endosc., 2012, 75(3), 467–473.

  • 6

    Dumonceau, J. M., Andriulli, A., Elmunzer, B. J., et al.: Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014. Endoscopy, 2014, 46(9), 799–815.

  • 7

    Hritz, I., Czakó, L., Dubravcsik, Z., et al.: Acute pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group. [Acut pancreatitis. A Magyar Hasnyálmirigy Munkacsoport bizonyítékon alapuló kezelési irányelvei.] Orv. Hetil., 2015, 156(7), 244–261. [Hungarian]

  • 8

    Patai, Á., Solymosi, N., Mohácsi, L., et al.: Prevention of post-ERCP pancreatitis: Review of current strategies in clinical practice. World J. Gastroenterol., 2015. [In press]

  • 9

    Cotton, P. B., Lehman, G., Vennes, J., et al.: Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest. Endosc., 1991, 37(3), 383–393.

  • 10

    Banks, P. A., Bollen, T. L., Dervenis, C., et al.: Classification of acute pancreatitis – 2012: revision of the Atlanta classification and definitions by international consensus. Gut, 2013, 62(1), 102–111.

  • 11

    Simon, L., Döbrönte, Z., Patai, Á.: Management of hypertensive dyskinesia of Oddi sphincter. Correlation between the frequency of complications from endoscopic sphincterotomy and the diameter of the common bile duct. [A hypertoniás Oddi-sphincter dyskinesis kezelése. Összefüggés az endoscopos sphincterotomia szövődményeinek gyakorisága és az epevezeték tágassága között.] Orv. Hetil., 1995, 136(31), 1659–1662. [Hungarian]

  • 12

    Freeman, M. L., DiSario, J. A., Nelson, D. B., et al.: Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest. Endosc., 2001, 54(4), 425–434.

  • 13

    Freeman, M. L.: Post-ERCP pancreatitis: patient and technique-related risk factors. JOP, 2002, 3(6), 169–176.

  • 14

    Masci, E., Mariani, A., Curioni, S., et al.: Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy, 2003, 35(10), 830–834.

  • 15

    Testoni, P. A., Mariani, A., Giussani, A., et al.: Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am. J. Gastroenterol., 2010, 105(8), 1753–1761.

  • 16

    Herszényi, L., Szmola, R., Tulassay, Z.: Clinical importance of pancreas divisum. [A pancreas divisum klinikai jelentősége.] Orv. Hetil., 2011, 152(44), 1764–1771. [Hungarian]

  • 17

    Szalai, O., Hoffer, K., Ringelhan, B., et al.: The use of MRCP effectively decreases the complications of ERCP in patients with suspected pancreatobiliary tract diseases (Abstract). Z. Gastroenterol., 2010, 48, A80.

  • 18

    Patai, Á., Solymosi, N., Patai, Á. V.: Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation. Results from a randomized study with sequential biliary intubation. J. Clin. Gastroenterol., 2015, 49(5), 429–437.

  • 19

    Döbrönte, Z., Simon, L., Patai, Á.: Management of Oddi sphincter dyskinesis. Results of drug therapy and sphincterotomy. [Az Oddi-sphincter dyskinesis kezelése. A gyógyszeres terápia és a sphincterotomia eredményei.] Orv. Hetil., 1995, 136(40), 2165–2167. [Hungarian]

  • 20

    Tenner, S., Baillie, J., DeWitt, J., et al.: American College of Gastroenterology guideline: Management of acute pancreatitis. Am. J. Gastroenterol., 2013, 108(9), 1400–1415.

  • 21

    Sagi, S. V., Schmidt, S., Fogel, E., et al.: Association of greater intravenous volume infusion with shorter hospitalization for patients with post-ERCP pancreatitis. J. Gastroenterol. Hepatol., 2014, 29(6), 1316–1320.

  • 22

    Buxbaum, J., Yan, A., Yeh, K., et al.: Aggressive hydration with lactated Ringer’s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin. Gastroenterol. Hepatol., 2014, 12(2), 303–307.e1.

  • 23

    Cortas, G. A., Mehta, S. N., Abraham, N. S., et al.: Selective cannulation of the common bile duct: a prospective randomized trial comparing standard catheters with sphincterotomes. Gastrointest. Endosc., 1999, 50(6), 775–779.

  • 24

    Cheon, Y. K., Cho, K. B., Watkins, J. L., et al.: Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest. Endosc., 2007, 65(3), 385–393.

  • 25

    Ogawa, M., Kawaguchi, Y., Kawashima, Y., et al.: A comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP. Tokai J. Exp. Clin. Med., 2013, 38(3), 109–113.

  • 26

    Tse, F., Yuan, Y., Moayyedi, P., et al.: Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy, 2013, 45(8), 605–618.

  • 27

    Mariani, A., Giussani, A., Di Leo, M., et al.: Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patients. Gastrointest. Endosc., 2012, 75(2), 339–346.

  • 28

    Kobayashi, G., Fujita, N., Imaizumi, K., et al.: Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: multicenter randomized controlled trial. Dig. Endosc., 2013, 25(3), 295–302.

  • 29

    Gyökeres, T., Duhl, J., Varsányi, M., et al.: Double guide wire placement for endoscopic pancreaticobiliary procedures. Endoscopy, 2003, 35(1), 95–96.

  • 30

    Yoo, Y. W., Cha, S. W., Lee, W. C., et al.: Double guidewire technique vs. transpancreatic precut sphincterotomy in difficult biliary cannulation. World J. Gastroenterol., 2013, 19(1), 108–114.

  • 31

    Cennamo, V., Fuccio, L., Zagari, R. M., et al.: Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy, 2010, 42(5), 381–388.

  • 32

    Freeman, M. L., Overby, C., Qi, D.: Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest. Endosc., 2004, 59(1), 8–14.

  • 33

    Das, A., Singh, P., Sivak, M. V. Jr., et al.: Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest. Endosc., 2007, 65(7), 960–968.

  • 34

    Madácsy, L., Kurucsai, G., Joó, I., et al.: Rescue ERCP and insertion of a small-caliber pancreatic stent to prevent the evolution of severe post-ERCP pancreatitis: a case-controlled series. Surg. Endosc., 2009, 23(8), 1887–1893.

  • 35

    Tulassay, Z., Papp, J.: The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography. Gastrointest. Endosc., 1991, 37(1), 48–50.

  • 36

    Tulassay, Z., Döbrönte, Z., Prónai, L., et al.: Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Aliment. Pharmacol. Ther., 1998, 12(11), 1109–1112.

  • 37

    Herszényi, L., Tulassay, Z.: Octreotide in the prevention of post-ERCP pancreatic injury. Am. J. Gastroenterol., 2007, 102(7), 1539–1540.

  • 38

    Herszényi, L., Mihály, E., Tulassay, Z.: Somatostatin and gastrointestinal tract. Clinical experiences. [A szomatosztatin és az emésztőrendszer. Klinikai tapasztalatok.] Orv. Hetil., 2013, 154(39), 1535–1540.

  • 39

    Concepción-Martín, M., Gómez-Oliva, C., Juanes, A., et al.: Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial. Endoscopy, 2014, 46(10), 851–856.

  • 40

    Bai, Y., Ren, X., Zhang, X. F., et al.: Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial. Endoscopy, 2015 Jan 15. [Epub ahead of print]

  • 41

    Ding, J., Jin, X., Pan, Y., et al.: Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials. PLoS One, 2013, 8(10), e75645.

  • 42

    Sotoudehmanesh, R., Eloubeidi, M. A., Asgari, A. A., et al.: A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis. Am. J. Gastroenterol., 2014, 109(6), 903–909.

  • 43

    Elmunzer, B. J., Waljee, A. K., Elta, G. H., et al.: A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut, 2008, 57(9), 1262–1267.

  • 44

    Sun, H. L., Han, B., Zhai, H. P., et al.: Rectal NSAIDs for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials. Surgeon, 2014, 12(3), 141–147.

  • 45

    McGettigan, P., Henry, D.: Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA, 2006, 296(13), 1633–1644.

  • 46

    Patai, Á., Solymosi, N., Patai, Á. V.: Does rectal indomethacin given for prevention of post-ERCP pancreatitis increase bleeding after biliary endoscopic sphincterotomy or cardiovascular mortality? Post hoc analysis using prospective clinical trial data. Medicine (Baltimore), 2014, 93(26), e159.

  • 47

    Elmunzer, B. J., Higgins, P. D., Saini, S. D., et al.: Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am. J. Gastroenterol., 2013, 108(3), 410–415.

  • 48

    Akbar, A. A., Abu Dayyeh, B. K., Baron, T. H., et al.: Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin. Gastroenterol. Hepatol., 2013, 11(7), 778–783.

  • 49

    Choksi, N. S., Fogel, E. L., Cote, G. A., et al.: The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement. Gastrointest. Endosc., 2015, 81(1), 150–155.

  • 50

    Nicolás-Pérez, D., Castilla-Rodríguez, I., Gimeno-García, A. Z., et al.: Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A cost-effectiveness analysis. Pancreas, 2015, 44(2), 204–210.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 84 80 12
PDF Downloads 98 96 9